These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 1826213

  • 1. The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels.
    Fogari R, Zoppi A, Tettamanti F, Malamani G, Pasotti C.
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1287-90. PubMed ID: 1826213
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effect of celiprolol and nifedipine on blood pressure and plasma lipids.
    van Hoof R, Desager JP, Harvengt C, Fagard R, Lijnen P, Peerenboom P, Staessen J, Thijs L, Van Mieghem W, Amery A.
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):268-73. PubMed ID: 1381018
    [Abstract] [Full Text] [Related]

  • 3. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
    Fogari R, Zoppi A, Corradi L, Preti P, Mugellini A, Lusardi P.
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):534-9. PubMed ID: 10218722
    [Abstract] [Full Text] [Related]

  • 4. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Malamani G, Corradi L.
    J Cardiovasc Pharmacol; 1989 Apr; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [Abstract] [Full Text] [Related]

  • 5. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
    Fogari R, Zoppi A, Malamani GD, Marasi G, Vanasia A, Villa G.
    Br J Clin Pharmacol; 1995 May; 39(5):471-6. PubMed ID: 7669481
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
    Fogari R, Zoppi A, Tettamanti F, Poletti L, Rizzardi G, Fiocchi G.
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
    [Abstract] [Full Text] [Related]

  • 7. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
    Bur A, Woisetschläger C, Herkner H, Derhaschnig U, Quehenberger P, Hirschl MM.
    Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
    [Abstract] [Full Text] [Related]

  • 8. A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients.
    Milne RJ, Vander Hoorn S, Jackson RT.
    Pharmacoeconomics; 1997 Sep; 12(3):384-408. PubMed ID: 10170463
    [Abstract] [Full Text] [Related]

  • 9. Comparative effects of atenolol versus celiprolol on serum lipids and blood pressure in hyperlipidemic and hypertensive subjects.
    Dujovne CA, Eff J, Ferraro L, Goldstein RJ, Gotto AM, Hall WD, Harris WS, Held SJ, Herd A, Hunninghake DB.
    Am J Cardiol; 1993 Nov 15; 72(15):1131-6. PubMed ID: 8237801
    [Abstract] [Full Text] [Related]

  • 10. Lipid profile improvement following celiprolol.
    Herrmann JM, von Heyman F, Freischütz G.
    J Int Med Res; 1988 Nov 15; 16 Suppl 1():39A-46A. PubMed ID: 2906016
    [Abstract] [Full Text] [Related]

  • 11. Effects of celiprolol on serum lipids in systemic hypertension.
    Herrmann JM, Bischof F, Von Heymann F, Freischuetz G, Burghagen H.
    Am J Cardiol; 1988 Feb 10; 61(5):41C-44C. PubMed ID: 2963524
    [Abstract] [Full Text] [Related]

  • 12. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
    van Zyl AI, Jennings AA, Bateman ED, Opie LH.
    Chest; 1989 Jan 10; 95(1):209-13. PubMed ID: 2562825
    [Abstract] [Full Text] [Related]

  • 13. Celiprolol in systemic hypertension.
    Frishman WH, Flamenbaum W, Schoenberger J, Schwartz GL, Vidt DG, Neri GS, Greenberg S, Lazar E, Godfrey JC, Stevenson A.
    Am J Cardiol; 1989 Apr 01; 63(12):839-42. PubMed ID: 2522723
    [Abstract] [Full Text] [Related]

  • 14. Effects of antihypertensive drugs on coronary artery disease risk: a meta-analysis.
    Howes LG, Lykos D, Rennie GC.
    Clin Exp Pharmacol Physiol; 1996 Apr 01; 23(6-7):555-8. PubMed ID: 8800583
    [Abstract] [Full Text] [Related]

  • 15. Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
    González Maqueda I.
    Coron Artery Dis; 1994 Nov 01; 5(11):909-18. PubMed ID: 7719523
    [Abstract] [Full Text] [Related]

  • 16. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR, Johnson B, Vaccarino V, Montanari G, Cremoncini M, Gianfranceschi G, Sirtori M, Dujovne CA.
    Clin Pharmacol Ther; 1989 Jun 01; 45(6):617-26. PubMed ID: 2567218
    [Abstract] [Full Text] [Related]

  • 17. [The effect of celiprolol hydrochloride for lipid metabolism--especially for the low density lipoprotein particle size].
    Totsuka M, Miyashita Y, Ito Y, Oyama T, Hashiguti S, Watanabe H, Shirai K, Ban T, Ishihara H, Yamamoto K, Kawano E, Mori J, Kanechi M.
    Nihon Ronen Igakkai Zasshi; 2001 May 01; 38(3):352-9. PubMed ID: 11431890
    [Abstract] [Full Text] [Related]

  • 18. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H, Schmidt J, Derendorf H.
    Int J Clin Pharmacol Ther; 2003 Jan 01; 41(1):22-9. PubMed ID: 12564742
    [Abstract] [Full Text] [Related]

  • 19. A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.
    Herrmann JM, Mayer EO.
    Am Heart J; 1988 Nov 01; 116(5 Pt 2):1416-21. PubMed ID: 2903652
    [Abstract] [Full Text] [Related]

  • 20. A randomized double-blind study of atenolol and celiprolol in mild to moderate hypertension.
    Silke B, Rosenthal F, Taylor S.
    J Cardiovasc Pharmacol; 1986 Nov 01; 8 Suppl 4():S122-6. PubMed ID: 2427841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.